PATENT CLAIM ANALYSIS

Application Number: 15554419
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-02
Patent Classification: ["514", "285000"]

Abstract:
Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.

Claim (Index 25):
The method of  claim 24 , wherein the resistant cancer is resistant to one or more BRAF inhibitors or one or more MEK inhibitors.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15546165', '15329183', '15050045', '14510711', '16062680']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047677793538596
- 35 USC 102 Novelty (BERT): 0.5374634979549382
- Combined Prediction Score: 0.7780373512139674
- Mean Citation Score: 334.73239
- Max Citation Score: 381.3447
- Similarity Product: 211.1632777958393

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test